Open AccessHead-and-neck cancer patients beyond 2 years of disease control
Author(s) -
Trinanjan Basu,
Shikha Goyal,
Tejinder Kataria,
Deepak Gupta
Publication year - 2019
Publication title -
journal of cancer research and therapeutics/journal of cancer research and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.475
H-Index - 39
eISSN - 0973-1482
pISSN - 1998-4138
DOI - 10.4103/jcrt.jcrt_1459_16
Subject(s) - head and neck cancer , medicine , swallowing , quality of life (healthcare) , disease , head and neck , stage (stratigraphy) , cancer , physical therapy , radiation therapy , surgery , nursing , paleontology , biology
Over a decade of intensity-modulated radiotherapy (IMRT) improved the toxicity profile among head-and-neck cancer patients and also improved the quality of life (QOL). Several parameters' few subjective and few objectives have documented various aspects related to QOL. Patients surviving beyond a certain period will have few unattended concern. A single questionnaire-based evaluation might answer few untouched issues. This brief communication formulated such an indigenous single-institution scale named IMRT late-effect assessment scale (ILEA). The preliminary analysis identified concerns related to dryness of mouth, swallowing habit change, and fear of disease recurrence. Future large-scale prospective evaluation is needed.